References
- Buchdunger E, Zimmermann J, Mett H, Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2 phenylaminopyrimidine derivative. Cancer Res 1996;56:100–104.
- Druker BJ, Tamura S, Buchdunger E, Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996;2:561–566.
- Druker BJ. Translation of the Philadelphia chromosome into therapy for CML. Blood 2008;112:4808–4817.
- Shah NP, Sawyers CL. Mechanisms of resistance to STI571 in Philadelphia chromosome associated leukemias. Oncogene 2003;20:7389–7395.
- La Rosée P, Deininger MW. Resistance to imatinib: mutations and beyond. Semin Hematol 2010;47:335–343.